As the number of registered medical marijuana patients continues to grow across the state, Trulieve Cannabis Corp. (CSE: TRUL; OTCQX: TCNNF) just opened dispensary number 33 in Florida. 

This latest storefront is now up and running in Key West and is aimed at serving patients in the Florida Keys region. 

More than 260,000 patients have registered through the state’s medical marijuana program as of September, with north of 2,000 physicians assisting patients in gaining access to a medical card. 

Aside from offering products to walk-in patients at those 33 separate locations, Trulieve has also launched a statewide home delivery service, which is a model now being utilized in states like California and Nevada by other cannabis companies.  

Discussing the company’s latest effort to increase access in another region of the state, Trulieve Chief Executive Officer Kim Rivers commented: 

Florida has one of the fastest growing registries in the medical cannabis space, with thousands of patients being added each week seeking natural yet effective relief. Expanding direct access to these medications, especially to patients who may not have the ability to visit a physical storefront in the past, is always going to be our focus.

The Key West location follows the launch of a Port Charlotte dispensary last week, which was marked by a grand opening celebration offering 25% discounts to Florida patients. 

In other recent news, Trulieve just recruited both a new Director of Corporate Growth and a Director of Wholesale to oversee large-scale expansion projects. The company additionally began selling O.penVAPE pens and cartridges in Florida earlier this summer. 

While vape products have skyrocketed in popularity on both the CBD and THC sides this year, the fate of flavoured vape cartridges is currently up in the air after a string of negative news stories about lung issues suspected to be caused by vaping. 

That uncertainty on the future of vaping in the United States may be a contributing factor in the company’s current stock price, which is sitting at $8.73 a share. Trulieve’s stock has been on a regular decline over the past five months, dropping from the high $14 range back in April. 

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.